Literature DB >> 2809213

Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs.

N M Wassef1, S H Johnson, G M Graeber, G M Swartz, C L Schultz, J R Hailey, A J Johnson, D G Taylor, R L Ridgway, C R Alving.   

Abstract

Antoantibodies to cholesterol were detected and purified from normal (nonimmunized) pig serum. The antibodies were assayed by ELISA with crystalline cholesterol as an Ag and by C-dependent damage to cholesterol-laden liposomes. Intravenous injection of liposomes containing cholesterol into anesthetized animals caused decreased hemolytic complement titers, and induced a reaction consisting of transient neutropenia, thrombocytopenia, respiratory distress, cyanosis, pulmonary and systemic hypertension, and decreased cardiac output. Plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha increased 1300 and 200%, respectively, and leukocyte and platelet counts decreased by 36 and 38%, respectively. Injection of cholesterol-free liposomes did not induce the reaction. These results show that naturally occurring autoantibodies to cholesterol can initiate C activation and can be associated with anaphylactoid reaction to exogenously administered cholesterol in pigs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809213

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.

Authors:  Christine M Murphy; Cliff Williams; Michael E Quinn; Brian Nicholson; Thomas Shoe; Michael C Beuhler; William P Kerns
Journal:  J Med Toxicol       Date:  2016-08-08

2.  Antibody dependent, complement mediated liver uptake of liposomes containing GM1.

Authors:  D Liu; Y K Song; F Liu
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

Review 3.  Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions.

Authors:  János Szebeni; Raj Bawa
Journal:  Biomedicines       Date:  2020-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.